Pathways significant by over representation analysis with respect to platinum drug sensitivity.

Pathways shown are those significantly over-represented in at least 3
drug lists for the inter-omic analysis. N/A indicates no quantified
metabolites were present in the pathway. Rows shown in bold are
those where the inter-omic analysis means that the pathway is
significantly associated with chemosensitivity to more drugs than
the individual analyses combined. The pathways are split into two
classes, metabolic and non-metabolic and then ordered so that the
pathways with improved detection in the inter-omic analysis are at
the top of the table.